US-based Insulet has unveiled positive results from a study investigating its Omnipod 5 system compared to insulin pump therapy with continuous glucose monitoring (CGM). Insulet’s Omnipod 5 is a ...

The lawsuit revolved around Insulet's Omnipod tubeless insulin pump – used with continuous glucose monitors (CGMs) to create an artificial pancreas system used by diabetics – and claimed that ...

Insulet Corp.’s PODD groundbreaking Omnipod 5 Automated Insulin Delivery (“AID”) system ... As the top-rated and most prescribed pump in the United States, Omnipod 5 is waterproof, discreet ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the Omnipod 5 Automated Insulin Delivery System is now ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the fourth quarter ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated Insulin Delivery System is now ...

Acton, Massachusetts-based Insulet ... and sells insulin delivery systems for people with insulin-dependent diabetes. Valued at a market cap of $19.7 billion, the company’s Omnipod Insulin ...

Insulet Corp ... including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and ...

January 13, 2025--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today ...